Mesothelioma and Radical Surgery 2 (MARS 2): protocol for a multicentre randomised trial comparing (extended) pleurectomy decortication versus no (extended) pleurectomy decortication for patients with malignant pleural mesothelioma.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
01 09 2020
Historique:
entrez: 3 9 2020
pubmed: 3 9 2020
medline: 15 5 2021
Statut: epublish

Résumé

Mesothelioma remains a lethal cancer. To date, systemic therapy with pemetrexed and a platinum drug remains the only licensed standard of care. As the median survival for patients with mesothelioma is 12.1 months, surgery is an important consideration to improve survival and/or quality of life. Currently, only two surgical trials have been performed which found that neither extensive (extra-pleural pneumonectomy) or limited (partial pleurectomy) surgery improved survival (although there was some evidence of improved quality of life). Therefore, clinicians are now looking to evaluate pleurectomy decortication, the only radical treatment option left. The MARS 2 study is a UK multicentre open parallel group randomised controlled trial comparing the effectiveness and cost-effectiveness of surgery-(extended) pleurectomy decortication-versus no surgery for the treatment of pleural mesothelioma. The study will test the hypothesis that surgery and chemotherapy is superior to chemotherapy alone with respect to overall survival. Secondary outcomes include health-related quality of life, progression-free survival, measures of safety (adverse events) and resource use to 2 years. The QuinteT Recruitment Intervention is integrated into the trial to optimise recruitment. Research ethics approval was granted by London - Camberwell St. Giles Research Ethics Committee (reference 13/LO/1481) on 7 November 2013. We will submit the results for publication in a peer-reviewed journal. ISRCTN-ISRCTN44351742 and ClinicalTrials.gov-NCT02040272.

Identifiants

pubmed: 32873681
pii: bmjopen-2020-038892
doi: 10.1136/bmjopen-2020-038892
pmc: PMC7467531
doi:

Banques de données

ClinicalTrials.gov
['NCT02040272']
ISRCTN
['ISRCTN44351742']

Types de publication

Clinical Trial Protocol Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e038892

Subventions

Organisme : Department of Health
ID : 15/188/31
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K025643/1
Pays : United Kingdom
Organisme : Cancer Research UK
Pays : United Kingdom

Investigateurs

Athanasia Gravani (A)
Holly McKeon (H)
Wendy Underwood (W)
Rachel Brophy (R)
Nicola Farrar (N)
Victoria Hughes (V)
Jane Elliott (J)
Claire Matthews (C)
Philip Noyes (P)
Apostolos Nakas (A)
Louise Nelson (L)
Sara Tenconi (S)
Laura Socci (L)
Hilary Wood (H)
Helena Hanratty (H)
Helena Stanley (H)
Judith Moore (J)
Robert Rintoul (R)
Suzanne Miller (S)
Amy Gladwell (A)
Jenny Castedo (J)
Amanda Stone (A)
Charlotte Ingle (C)
Hayley Hewer (H)
Louise Li (L)
Eleanor Aynsley (E)
Andrea Watson (A)
Charlotte Jacobs (C)
Alison Hassall (A)
Masuma Begum (M)
Christopher Worth (C)
Ellie Piggott (E)
Elizabeth Nadin (E)
Victoria Ashford-Turner (V)
Matthew Callister (M)
Yvonne Summers (Y)
Raffaele Califano (R)
Laura Cove-Smith (L)
Matt Evison (M)
Maria Blinston (M)
Sara Waplington (S)
Amal Ismail (A)
Rachel Chant (R)
Asmita Desai (A)
Juliette Novasio (J)
Marie Kirwan (M)
Ian Morgan (I)
Victoria Lake (V)
Nichola Harris (N)
Simon Hodge (S)
Nadia Yousaf (N)
Nadza Tokaca (N)
Adam Januszewski (A)
Avani Athauda (A)
Anisha Ramessur (A)
Emily Grist (E)
Niamh Colman (N)
Michael Flynn (M)
Joan Joyce (J)
Sarah Vaughan (S)
Maria Piga (M)
Derya Sahin (D)
Agnieszka Yongue (A)
Emma Turay (E)
Mary O'Brien (M)
Jaishree Bhosle (J)
Rajiv Kumar (R)
Charlotte Milner-Watts (C)
Jessica Brown (J)
David Walder (D)
Alexandros Georgiou (A)
Xiaorong Wu (X)
Naila Kaudeer (N)
Kroopa Joshi (K)
Michael Davidson (M)
Shelize Khakoo (S)
Bee Ayite (B)
Kathryn Priest (K)
James Dobbyn (J)
Vasanthi Prathapan (V)
Deborah McCrimmon (D)
Natalie Ash (N)
Alison Norton (A)
Bianca Peet (B)
Libby Hennessy (L)
Rosemary Johnson (R)
Laura White (L)
Edward Armstrong (E)
Maria Coakley (M)
Scott Shepherd (S)
Narda Chaabouni (N)
Katherina Sreter (K)
Vasileios Angelis (V)
Mariko Morishita (M)
Jose Roca (J)
Mary Jane de los Reyes Lauigan (MJ)
Katrin Sainudeen (K)
Helen Morgan (H)
Abigail Hollingdale (A)
Chloe Eddings (C)
Holly Warman (H)
Jeremy Steele (J)
Jo Hargrave (J)
Resmi Jayachandran (R)
Pratistha Panday (P)
Austin McInnes (A)
Rocco Bilancia (R)
Julie Buckley (J)
Elizabeth Boyd (E)
Natalie Zahan-Evans (N)
Anna Morley (A)
Adela Dann (A)
Eleanor Mishra (E)
Pinelopi Gkogkou (P)
Irene Harvey (I)
Hilary Congdon (H)
Alison Ray (A)
Jehan Mansi (J)
Amy Quinn (A)
Najib M Rahman (NM)
Jack Seymour (J)
Hannah Ball (H)
Meenali Chitnis (M)
Eirini Petroyannou (E)
Kimberley Snoad (K)
Monica Tavares Barbosa (M)
Gary Middleton (G)
Philip Earwaker (P)
Haider Abbas (H)
Parminder Sohal (P)
Marcus Flather (M)
Paul Beckett (P)
Carol Tan (C)
Fergus Gleeson (F)
Fergus MacBeth (F)
Mavis Nye (M)
Harvey Pass (H)
Pauline Leonard (P)
Tom Treasure (T)
Linda Sharples (L)
Valerie Rusch (V)
Mark Britton (M)
Robin Rudd (R)
Joseph S Friedberg (JS)
Peter Goldstraw (P)

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Stat Med. 2011 Feb 20;30(4):377-99
pubmed: 21225900
Lung Cancer. 2013 Sep;81(3):319-327
pubmed: 23769317
J Clin Oncol. 2003 Jul 15;21(14):2636-44
pubmed: 12860938
Lancet Oncol. 2011 Aug;12(8):763-72
pubmed: 21723781
Qual Life Res. 2011 Dec;20(10):1727-36
pubmed: 21479777
J R Soc Med. 2011 Feb;104(2):69-80
pubmed: 21282797
Lancet. 2014 Sep 20;384(9948):1118-27
pubmed: 24942631
J Clin Epidemiol. 2016 Dec;80:8-15
pubmed: 27498376
J Thorac Oncol. 2012 Apr;7(4):737-43
pubmed: 22425923
Qual Health Res. 2019 Apr;29(5):672-679
pubmed: 30791819
Trials. 2016 Jun 08;17(1):283
pubmed: 27278130
Lancet. 1995 Mar 4;345(8949):535-9
pubmed: 7776771
J Clin Epidemiol. 2019 Feb;106:108-120
pubmed: 30339938
J Thorac Oncol. 2011 Aug;6(8):1304-12
pubmed: 21847060
Eur J Cardiothorac Surg. 2010 Sep;38(3):241-4
pubmed: 20356754
Clin Trials. 2017 Apr;14(2):211-218
pubmed: 28135839
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801

Auteurs

Eric Lim (E)

Academic Division of Thoracic Surgery, Royal Brompton and Harefield NHS Trust, London, UK e.lim@rbht.nhs.uk.

Liz Darlison (L)

The Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester, UK.
Mesothelioma UK, Glenfield Hospital, Leicester, UK.

John Edwards (J)

Cardiothoracic Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.

Daisy Elliott (D)

Population Health Sciences, University of Bristol, Bristol, UK.

D A Fennell (DA)

Cancer Research UK Centre Leicester, University Hospitals of Leicester NHS Trust, Leicester, UK.

Sanjay Popat (S)

Department of Medicine, Royal Marsden NHS Foundation Trust, London, UK.

Robert C Rintoul (RC)

Department of Thoracic Oncology, Papworth Hospital NHS Foundation Trust, Cambridge, UK.

David Waller (D)

Department of Thoracic Surgery, Barts Health NHS Trust, London, UK.

Clinton Ali (C)

The Beatson West of Scotland Cancer Centre, Gartnavel General Hospital, Glasgow, UK.

Andrea Bille (A)

Thoracic Surgery, Guy's and Saint Thomas' Hospitals NHS Trust, London, UK.

Liz Fuller (L)

Respiratory Medicine, South Tyneside NHS Foundation Trust, South Shields, UK.

Andreea Ionescu (A)

Lung Cancer, Aneurin Bevan University Health Board, Newport, UK.

Manjusha Keni (M)

Oncology, Derby Teaching Hospitals NHS Foundation Trust, Derby, UK.

Alan Kirk (A)

Department of Thoracic Surgery, Golden Jubilee National Hospital, Clydebank, UK.

Pek Koh (P)

Department of Oncology, New Cross Hospital, Wolverhampton, UK.

Kelvin Lau (K)

Department of Thoracic Surgery, Barts Health NHS Trust, London, UK.

Talal Mansy (T)

Oncology, South Tees Hospitals NHS Foundation Trust, Middlesbrough, UK.

Nick A Maskell (NA)

Academic Respiratory Unit, School of Clinical Sciences, University of Bristol, Bristol, UK.
Respiratory Research Unit, North Bristol NHS Trust, Westbury on Trym, UK.

Richard Milton (R)

Thoracic Surgery Department, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

Dakshinamoorthy Muthukumar (D)

Oncology, Colchester Hospital University NHS Foundation Trust, Colchester, UK.

Tony Pope (T)

Clatterbridge Cancer Centre, Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, UK.

Amy Roy (A)

Plymouth Oncology Centre, University Hospitals Plymouth NHS Trust, Plymouth, UK.

Riyaz Shah (R)

Kent Oncology Centre, Maidstone and Tunbridge Wells NHS Trust, Maidstone, UK.

Jonathan Shamash (J)

Department of Medical Oncology, Barts Health NHS Trust, London, UK.

Zacharias Tasigiannopoulos (Z)

The Oncology Care Team, Norfolk and Norwich University Hospital NHS Trust, Norwich, UK.

Paul Taylor (P)

Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.

Sarah Treece (S)

Heamatology and Oncology Unit, North West Anglia NHS Foundation Trust, Peterborough, UK.

Kate Ashton (K)

Bristol Trials Centre (CTEU), University of Bristol, Bristol, UK.

Rosie Harris (R)

Bristol Trials Centre (CTEU), University of Bristol, Bristol, UK.

Katherine Joyce (K)

Bristol Trials Centre (CTEU), University of Bristol, Bristol, UK.

Barbara Warnes (B)

Bristol Trials Centre (CTEU), University of Bristol, Bristol, UK.

Nicola Mills (N)

Population Health Sciences, University of Bristol, Bristol, UK.

Elizabeth A Stokes (EA)

Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Chris Rogers (C)

Bristol Trials Centre (CTEU), University of Bristol, Bristol, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH